SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,913 | +6.5% | 651 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $74,094 | -16.9% | 647 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $89,176 | +6.4% | 647 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $83,838 | +16.4% | 647 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +44.0% | 647 | -2.1% | 0.00% | +100.0% |
| Q2 2022 | $50,000 | -3.8% | 661 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $52,000 | -10.3% | 661 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $58,000 | – | 647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |